Haifeng Lian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haifeng Lian has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Chengxia Liu
Department of Gastroenterology, Binzhou Medical University Hospital, Binzhou, China
2 shared publicationsDan Li
Department of Nursing, Binzhou Medical University, Yantai, Shandong, 264100, PR China
2 shared publicationsPeijia Cong
Department of Gastroenterology, The First Medical College of Binzhou Medical University, Yantai, China
2 shared publicationsYuqiang Zhang
Yantai Affiliated Hospital of Binzhou Medical University, Department of Clinical Laboratory, Yantai, China
2 shared publicationsZhe Sun
Department of Gastroenterology, Binzhou Medical University Hospital, Binzhou, China
2 shared publicationsZiru Tan
Department of Immunology, Binzhou Medical University, Yantai, Shandong, 264100, PR China
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Immunobiology
- Vol. 231 (6) , 153258
Putrescine alters the composition of interstitial dendritic cell subsets by suppressing Cybb-dependent oxidative phosphorylation
- 15 October 2026
- Published by Elsevier in Immunobiology
- Vol. 231 (6) , 153258
Open AccessPutrescine alters the composition of interstitial dendritic cell subsets by suppressing Cybb-dependent oxidative phosphorylation
- Open Access
Multiomics analysis of polyamine metabolism in colorectal cancer, highlighting the key role of extracellular putrescine in impairing CXCR6 + CD8 + T cell anti-tumor activity
The contribution of putrescine (PUT) metabolism to impaired tumor immunosurveillance in colorectal cancer (CRC) requires a thorough examination of its biosynthesis, catabolism, and transport during tumor development. This study found, unexpectedly, that a better prognosis was associated with higher expression of the PUT biosynthesis genes ODC1 and AGMAT , while elevated expression of biosynthesis inhibitors and transport genes predicted worse outcomes. Two independent cohorts were deconvoluted by integrating data from 517,191 cells across 221 samples from 131 subjects. Higher percentages of epithelial subpopulations with low PUT transport scores were linked to improved prognosis. In contrast, greater proportions of T/natural killer/ILC cells with low biosynthesis but relatively higher transport scores were associated with poorer outcomes. PUT supplementation in HCT-116 and RKO cells promoted the tumor cell proliferation, but had no effect on cell migration or the expression of N-cadherin and E-cadherin. CXCR6 + CD8 + T cells, which were more prevalent in tumor tissue, exhibited significantly higher cytotoxicity compared to CXCR6 − CD8 + T cells, as assessed using updated gene sets for T cell functional evaluation . However, CXCR6 + CD8 + T cells also displayed elevated markers of exhaustion. Notably, higher CXCR6 expression and increased infiltration of CXCR6 + CD8 + T cells correlated with improved prognosis in both mismatch repair-proficient and mismatch repair-deficient CRC. To estimate the local accumulation of PUT around CXCR6 + CD8 + T cells, a novel “Pi value” was defined. A negative correlation was found between Pi values and both the cytotoxic activity and pro-inflammatory potential of these cells. Further investigation using a CRC tumor antigen-based in vitro system for the efficient induction of CXCR6 + CD8 + T cells revealed that extracellular PUT inhibits their cytotoxic function. Additionally, in a Dextran Sulfate Sodium (DSS)-induced colitis model combined with single-cell RNA sequencing, PUT supplementation resulted in the elimination of CXCR6 + CD8 + T cells in the colon. These findings provide new insights into how polyamine metabolism, particularly involving extracellular PUT, impairs the anti-tumor activity of CXCR6 + CD8 + T cells, potentially contribut ing to CRC progression.
Open AccessMultiomics analysis of polyamine metabolism in colorectal cancer, highlighting the key role of extracellular putrescine in impairing CXCR6 + CD8 + T cell anti-tumor activity
The contribution of putrescine (PUT) metabolism to impaired tumor immunosurveillance in colorectal cancer (CRC) requires a thorough examination of its biosynthesis, catabolism, and transport during tumor development. This study found, unexpectedly, that a better prognosis was associated with higher expression of the PUT biosynthesis genes ODC1 and AGMAT , while elevated expression of biosynthesis inhibitors and transport genes predicted worse outcomes. Two independent cohorts were deconvoluted by integrating data from 517,191 cells across 221 samples from 131 subjects. Higher percentages of epithelial subpopulations with low PUT transport scores were linked to improved prognosis. In contrast, greater proportions of T/natural killer/ILC cells with low biosynthesis but relatively higher transport scores were associated with poorer outcomes. PUT supplementation in HCT-116 and RKO cells promoted the tumor cell proliferation, but had no effect on cell migration or the expression of N-cadherin and E-cadherin. CXCR6 + CD8 + T cells, which were more prevalent in tumor tissue, exhibited significantly higher cytotoxicity compared to CXCR6 − CD8 + T cells, as assessed using updated gene sets for T cell functional evaluation . However, CXCR6 + CD8 + T cells also displayed elevated markers of exhaustion. Notably, higher CXCR6 expression and increased infiltration of CXCR6 + CD8 + T cells correlated with improved prognosis in both mismatch repair-proficient and mismatch repair-deficient CRC. To estimate the local accumulation of PUT around CXCR6 + CD8 + T cells, a novel “Pi value” was defined. A negative correlation was found between Pi values and both the cytotoxic activity and pro-inflammatory potential of these cells. Further investigation using a CRC tumor antigen-based in vitro system for the efficient induction of CXCR6 + CD8 + T cells revealed that extracellular PUT inhibits their cytotoxic function. Additionally, in a Dextran Sulfate Sodium (DSS)-induced colitis model combined with single-cell RNA sequencing, PUT supplementation resulted in the elimination of CXCR6 + CD8 + T cells in the colon. These findings provide new insights into how polyamine metabolism, particularly involving extracellular PUT, impairs the anti-tumor activity of CXCR6 + CD8 + T cells, potentially contribut ing to CRC progression.
- Open Access
Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway
Neutrophils significantly accumulate within the inflamed intestinal mucosa of patients with inflammatory bowel disease (IBD), where the farnesoid X receptor (FXR) is typically downregulated. However, the mechanisms by which FXR modulates neutrophil‐mediated mucosal inflammation in IBD remain elusive. Here, we demonstrated that FXR expression is markedly decreased in neutrophils from patients with active IBD. Fxr −/− mice exhibited exacerbated colitis following DSS insults or Citrobacter rodentium infection, evidenced by heightened neutrophil‐driven immune responses including increased neutrophil infiltration and neutrophil extracellular trap (NET) formation. Adoptive transfer of Fxr −/− neutrophils into WT recipients exacerbated DSS‐induced intestinal inflammation, indicating that FXR suppresses the pathogenic activity of neutrophils in a neutrophil‐intrinsic manner. An ex vivo functional assay revealed that Fxr −/− neutrophils display elevated ROS production, NET formation, and migratory capacity upon inflammatory challenge. Mechanistically, RNA‐sequencing and functional assays revealed enhanced mTORC1 signaling and glycolysis in Fxr −/− neutrophils. Consistently, pharmacological activation of FXR with INT‐747 significantly restrained the mTORC1‐glycolysis‐mediated proinflammatory responses in neutrophils from IBD patients. Our findings identify FXR as a critical regulator of neutrophil‐mediated mucosal inflammation via the mTORC1‐glycolysis pathway, highlighting its therapeutic potential in IBD.
Open AccessDysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway
Neutrophils significantly accumulate within the inflamed intestinal mucosa of patients with inflammatory bowel disease (IBD), where the farnesoid X receptor (FXR) is typically downregulated. However, the mechanisms by which FXR modulates neutrophil‐mediated mucosal inflammation in IBD remain elusive. Here, we demonstrated that FXR expression is markedly decreased in neutrophils from patients with active IBD. Fxr −/− mice exhibited exacerbated colitis following DSS insults or Citrobacter rodentium infection, evidenced by heightened neutrophil‐driven immune responses including increased neutrophil infiltration and neutrophil extracellular trap (NET) formation. Adoptive transfer of Fxr −/− neutrophils into WT recipients exacerbated DSS‐induced intestinal inflammation, indicating that FXR suppresses the pathogenic activity of neutrophils in a neutrophil‐intrinsic manner. An ex vivo functional assay revealed that Fxr −/− neutrophils display elevated ROS production, NET formation, and migratory capacity upon inflammatory challenge. Mechanistically, RNA‐sequencing and functional assays revealed enhanced mTORC1 signaling and glycolysis in Fxr −/− neutrophils. Consistently, pharmacological activation of FXR with INT‐747 significantly restrained the mTORC1‐glycolysis‐mediated proinflammatory responses in neutrophils from IBD patients. Our findings identify FXR as a critical regulator of neutrophil‐mediated mucosal inflammation via the mTORC1‐glycolysis pathway, highlighting its therapeutic potential in IBD.
- Open Access
- 1 November 2024
- Published by Wolters Kluwer Health in Indian Journal of Pharmacology
- Vol. 56 (6) , 430-436
Putrescine can inhibit germinal center B cell differentiation by inducing reactive oxygen species generation
Polyamine synthesis and abnormal regulation of B cell differentiation occur concurrently in various diseases. We investigated whether putrescine could suppress germinal center B cell (GCB) differentiation by inducing reactive oxygen species (ROS) generation. The results of flow cytometry analysis revealed that putrescine did not affect B cell apoptosis and cell cycle. The results of RT-qPCR and western blotting revealed that putrescine could inhibit CD79a phosphorylation rather than total expression. Using an O2K high-resolution respirometer, we illustrated that putrescine increased the oxygen consumption rate in the basal mitochondrial respiration stage, ATP-coupled respiration stage, and maximum respiration stage. Similarly, it also elevated ROS generation across stages in B cells and reduced the proportion of GCB cells. Meanwhile, ROS scavenging by SOD could reverse such inhibitory effects on GCB cells. We concluded that putrescine could inhibit the differentiation of GCB cells by reducing CD79a phosphorylation and increasing ROS levels in GCB cells.
- 1 November 2024
- Published by Wolters Kluwer Health in Indian Journal of Pharmacology
- Vol. 56 (6) , 430-436
Open AccessPutrescine can inhibit germinal center B cell differentiation by inducing reactive oxygen species generation
Polyamine synthesis and abnormal regulation of B cell differentiation occur concurrently in various diseases. We investigated whether putrescine could suppress germinal center B cell (GCB) differentiation by inducing reactive oxygen species (ROS) generation. The results of flow cytometry analysis revealed that putrescine did not affect B cell apoptosis and cell cycle. The results of RT-qPCR and western blotting revealed that putrescine could inhibit CD79a phosphorylation rather than total expression. Using an O2K high-resolution respirometer, we illustrated that putrescine increased the oxygen consumption rate in the basal mitochondrial respiration stage, ATP-coupled respiration stage, and maximum respiration stage. Similarly, it also elevated ROS generation across stages in B cells and reduced the proportion of GCB cells. Meanwhile, ROS scavenging by SOD could reverse such inhibitory effects on GCB cells. We concluded that putrescine could inhibit the differentiation of GCB cells by reducing CD79a phosphorylation and increasing ROS levels in GCB cells.
- 19 February 2024
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 119 (4) , 1027-1035
Parenteral n–3 polyunsaturated fatty acids supplementation improves postoperative recovery for patients with Crohn’s disease after bowel resection: a randomized, unblinded controlled clinical trial
- 19 February 2024
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 119 (4) , 1027-1035
Parenteral n–3 polyunsaturated fatty acids supplementation improves postoperative recovery for patients with Crohn’s disease after bowel resection: a randomized, unblinded controlled clinical trial
- Open Access
- 2 March 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1153344
The colonic interleukin-19 aggravates the dextran sodium sulfate/stress-induced comorbidities due to colitis and anxiety
Comorbidities due to inflammatory bowel disease (IBD) and anxiety are commonly acknowledged; however, their underlying basis is unclear. In the current study, we first conducted a clinical retrospective analysis to identify the enhancive incidence rate of IBD before or after the epidemic of Corona Virus Disease 2019 (COVID-19), with higher Generalized Anxiety Disorder-7 (GAD-7), as well as poorer Gastrointestinal Quality of Life Index (GIQLI). Then, the dextran sodium sulfate (DSS) and chronic unpredictable stress (CUS)-induced IBD and anxiety comorbid models were established with the correlational relations between symptoms of IBD and anxiety-related behaviors. We found dysfunctional up-regulation of a new inflammatory factor interleukin (IL)-19 in the colon of DSS/CUS treated mice. Overexpression of IL-19 in colon induced anxious phenotypes, and accelerated the anxious condition and symptoms of colitis in the DSS/CUS model by promoting the expression of inducible nitric oxide synthase (iNOS), IL-1β, and IL-6 pro-inflammatory factors, and activating signal transducer and activator of transcription 3 (STAT3) signaling pathway in the colon. Furthermore, overexpression of IL-19 in the colon also reduced the expression levels of brain-derived neurotrophic factor (BDNF), extracellular signal-regulated kinase (ERK), and cAMP-response element binding protein (CREB) signaling pathways activity in the hippocampus. These results suggest that IL-19 was a pivotal player in DSS/CUS-induced comorbidities of colitis and anxiety with different signaling pathways for the colon and hippocampus, which provides a candidate gene to explore the pathophysiology of comorbidities due to colitis and anxiety.
- 2 March 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1153344
Open AccessThe colonic interleukin-19 aggravates the dextran sodium sulfate/stress-induced comorbidities due to colitis and anxiety
Comorbidities due to inflammatory bowel disease (IBD) and anxiety are commonly acknowledged; however, their underlying basis is unclear. In the current study, we first conducted a clinical retrospective analysis to identify the enhancive incidence rate of IBD before or after the epidemic of Corona Virus Disease 2019 (COVID-19), with higher Generalized Anxiety Disorder-7 (GAD-7), as well as poorer Gastrointestinal Quality of Life Index (GIQLI). Then, the dextran sodium sulfate (DSS) and chronic unpredictable stress (CUS)-induced IBD and anxiety comorbid models were established with the correlational relations between symptoms of IBD and anxiety-related behaviors. We found dysfunctional up-regulation of a new inflammatory factor interleukin (IL)-19 in the colon of DSS/CUS treated mice. Overexpression of IL-19 in colon induced anxious phenotypes, and accelerated the anxious condition and symptoms of colitis in the DSS/CUS model by promoting the expression of inducible nitric oxide synthase (iNOS), IL-1β, and IL-6 pro-inflammatory factors, and activating signal transducer and activator of transcription 3 (STAT3) signaling pathway in the colon. Furthermore, overexpression of IL-19 in the colon also reduced the expression levels of brain-derived neurotrophic factor (BDNF), extracellular signal-regulated kinase (ERK), and cAMP-response element binding protein (CREB) signaling pathways activity in the hippocampus. These results suggest that IL-19 was a pivotal player in DSS/CUS-induced comorbidities of colitis and anxiety with different signaling pathways for the colon and hippocampus, which provides a candidate gene to explore the pathophysiology of comorbidities due to colitis and anxiety.
- Open Access
- 22 February 2022
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 759689
Exosomal miR-29b of Gut Origin in Patients With Ulcerative Colitis Suppresses Heart Brain-Derived Neurotrophic Factor
Background and Aims: While the interplay between heart and gut in inflammatory bowel disease (IBD) has previously been noted, how the inflamed gut impairs heart function remain elusive. We hypothesized that exosomal miRNAs of gut origin induce cardiac remodeling in IBD. Our aim was to identify plasma exosomal miRNAs that not only are of diagnostic value but also contribute to cardiac remodeling in patients with ulcerative colitis (UC).Methods: Plasma exosomes were isolated from UC patients and healthy control subjects and exosomal miRNAs were profiled by next-generation sequencing. Exosomal miR-29b levels in CCD841 CoN colon epithelial cells were detected by RT-qPCR. Exosomes packaged with miR-29b were incubated with H9c2 cells or administered to live mice.Results: The plasma exosomal miRNA profiles of the UC patients were significantly different from that of the controls and 20 miRNAs including miR-29b were differentially expressed. In CCD841 CoN cells, TNFα, IL-1β, and H2O2 significantly elevated miR-29b in both the cells and their secreted exosomes (p < 0.01), suggesting that intestinal epithelium secrets exosomes rich in miR-29b in IBD. In H9c2 myoblast cells, miR-29b modulated multiple genes including brain-derived neurotrophic factor (BDNF). Epithelial cell-derived exosomes packaged with miR-29b also attenuated BDNF and increased cleaved caspase 3, suggestive of apoptosis. Furthermore, tail vein injection of engineered exosomes with high levels of miR-29b suppressed BDNF and augmented cleaved caspase 3 in the heart of adult mouse (p < 0.01).Conclusion: Plasma exosomal miRNA profile could be a novel diagnostic approach for IBD. Excessive plasma exosomal miR-29b suppresses critical proteins like BDNF in IBD, leading to cardiac impairment.
- 22 February 2022
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 759689
Open AccessExosomal miR-29b of Gut Origin in Patients With Ulcerative Colitis Suppresses Heart Brain-Derived Neurotrophic Factor
Background and Aims: While the interplay between heart and gut in inflammatory bowel disease (IBD) has previously been noted, how the inflamed gut impairs heart function remain elusive. We hypothesized that exosomal miRNAs of gut origin induce cardiac remodeling in IBD. Our aim was to identify plasma exosomal miRNAs that not only are of diagnostic value but also contribute to cardiac remodeling in patients with ulcerative colitis (UC).Methods: Plasma exosomes were isolated from UC patients and healthy control subjects and exosomal miRNAs were profiled by next-generation sequencing. Exosomal miR-29b levels in CCD841 CoN colon epithelial cells were detected by RT-qPCR. Exosomes packaged with miR-29b were incubated with H9c2 cells or administered to live mice.Results: The plasma exosomal miRNA profiles of the UC patients were significantly different from that of the controls and 20 miRNAs including miR-29b were differentially expressed. In CCD841 CoN cells, TNFα, IL-1β, and H2O2 significantly elevated miR-29b in both the cells and their secreted exosomes (p < 0.01), suggesting that intestinal epithelium secrets exosomes rich in miR-29b in IBD. In H9c2 myoblast cells, miR-29b modulated multiple genes including brain-derived neurotrophic factor (BDNF). Epithelial cell-derived exosomes packaged with miR-29b also attenuated BDNF and increased cleaved caspase 3, suggestive of apoptosis. Furthermore, tail vein injection of engineered exosomes with high levels of miR-29b suppressed BDNF and augmented cleaved caspase 3 in the heart of adult mouse (p < 0.01).Conclusion: Plasma exosomal miRNA profile could be a novel diagnostic approach for IBD. Excessive plasma exosomal miR-29b suppresses critical proteins like BDNF in IBD, leading to cardiac impairment.
- Open Access
- 1 May 2016
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 9, 2865-2871
miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma
Increasing evidence suggests that microRNAs are associated with many important biologic processes in carcinogenesis. Despite ample research revealing the dysregualtion of miR-486-5p in various cancers, little is known about the roles of miR-486-5p in colorectal carcinoma (CRC). In this study, we investigated the biological functions and molecular mechanisms of miR-486-5p in CRC growth and invasion, discussing the potential of using miR-486-5p as a biomarker for colorectal cancers. Our data revealed that miR-486-5p was significantly downregulated in CRC tissues compared with the paracancer tissue by quantitative real-time polymerase chain reaction and that miR-486-5p was downregulated to a greater extent in advanced stage cancer (stage III and IV) as compared to early stage cancer (stage I and II). Luciferase reporter assay verified that neuropilin-2 was a direct functional target of miR-486-5p in the CRC cells, and upregulation of miR-486-5p in CRC cells negatively correlated with the expression of neuropilin-2. Furthermore, overexpression of miR-486-5p inhibited the tumor growth and lymphangiogenesis in nude mice, which was reversed by overexpression of neuropilin-2. Taken together, our study suggested miR-486-5p might be a suppressor of CRC.
- 1 May 2016
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 9, 2865-2871
Open AccessmiR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma
Increasing evidence suggests that microRNAs are associated with many important biologic processes in carcinogenesis. Despite ample research revealing the dysregualtion of miR-486-5p in various cancers, little is known about the roles of miR-486-5p in colorectal carcinoma (CRC). In this study, we investigated the biological functions and molecular mechanisms of miR-486-5p in CRC growth and invasion, discussing the potential of using miR-486-5p as a biomarker for colorectal cancers. Our data revealed that miR-486-5p was significantly downregulated in CRC tissues compared with the paracancer tissue by quantitative real-time polymerase chain reaction and that miR-486-5p was downregulated to a greater extent in advanced stage cancer (stage III and IV) as compared to early stage cancer (stage I and II). Luciferase reporter assay verified that neuropilin-2 was a direct functional target of miR-486-5p in the CRC cells, and upregulation of miR-486-5p in CRC cells negatively correlated with the expression of neuropilin-2. Furthermore, overexpression of miR-486-5p inhibited the tumor growth and lymphangiogenesis in nude mice, which was reversed by overexpression of neuropilin-2. Taken together, our study suggested miR-486-5p might be a suppressor of CRC.
- Open Access
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 23 (27) , 4335-4341
Overexpression of miR-486-5p suppresses tumor lymphangiogenesis in colorectal carcinoma by targeting neuropilin-2
目的: 探讨过表达microRNA-486-5p(miR-486-5p)对人大肠癌细胞系SW620体内生长的作用及其作用机制的研究. 方法: 构建miR-486-5p的过表达质粒, 体外脂质体法瞬时转染人大肠癌细胞SW620; 建立人大肠癌裸鼠皮下移植瘤模型, 实验组每3 d瘤周注射miR-486-5p过表达质粒, 对照组注射等量的空白载体. 每天观察肿瘤的生长情况并每3 d测量肿瘤的体积; 实时荧光定量-PCR(Real-time PCR)检测各组肿瘤组织中miR-486-5p的表达水平; 免疫组织化学技术检测移植瘤内神经纤毛蛋白-2(neuropilin-2, NRP2)及微淋巴管的的分布情况; Western blot技术检测各组移植瘤中NRP2蛋白的表达. 结果: 转染后, 实验组中miR-486-5p的相对表达量较对照组提高12.57±2.31倍, 过表达miR-486-5p后实验组裸鼠皮下移植瘤的生长速度较对照组明显减缓(PPP结论: 过表达miR-486-5p可明显抑制大肠癌细胞的生长, 抑制微淋巴管的生成, 这可能与下调NRP2蛋白的表达有关.
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 23 (27) , 4335-4341
Open AccessOverexpression of miR-486-5p suppresses tumor lymphangiogenesis in colorectal carcinoma by targeting neuropilin-2
目的: 探讨过表达microRNA-486-5p(miR-486-5p)对人大肠癌细胞系SW620体内生长的作用及其作用机制的研究. 方法: 构建miR-486-5p的过表达质粒, 体外脂质体法瞬时转染人大肠癌细胞SW620; 建立人大肠癌裸鼠皮下移植瘤模型, 实验组每3 d瘤周注射miR-486-5p过表达质粒, 对照组注射等量的空白载体. 每天观察肿瘤的生长情况并每3 d测量肿瘤的体积; 实时荧光定量-PCR(Real-time PCR)检测各组肿瘤组织中miR-486-5p的表达水平; 免疫组织化学技术检测移植瘤内神经纤毛蛋白-2(neuropilin-2, NRP2)及微淋巴管的的分布情况; Western blot技术检测各组移植瘤中NRP2蛋白的表达. 结果: 转染后, 实验组中miR-486-5p的相对表达量较对照组提高12.57±2.31倍, 过表达miR-486-5p后实验组裸鼠皮下移植瘤的生长速度较对照组明显减缓(PPP结论: 过表达miR-486-5p可明显抑制大肠癌细胞的生长, 抑制微淋巴管的生成, 这可能与下调NRP2蛋白的表达有关.